|
|
Other links at Articles > Nephrology |
| 3. |
Benefits of Sorafenib for Renal Cancer Not Age Dependent
|
|
|
New research suggests that older patients with advanced renal cell carcinoma glean as much benefit from sorafenib as do their younger counterparts. Moreover, the side effects seen with the drug were predictable and manageable, regardless of patient age. Reuters Health Information
|
| 4. |
Blacks With Chronic Kidney Disease Have Unique Survival Profile
|
|
|
Black patients younger than 65 years old with end-stage renal disease (ESRD) have the highest mortality rates. However, as they grow older, their survival rates become similar to patients of other races and ethnic groups. Reuters Health Information
|
|
|